This Consortium of 10 geographically-dispersed clinical research sites will continue to study rare diseases of the airways that are associated wit defective mucociliary clearance and airway host defense mechanisms, which result in chronic airways infection and/or bronchiectasis. These disorders include Primary Ciliary Dyskinesia (PCD), idiopathic bronchiectasis (IB), cystic fibrosis (CF), airway infection with non-tuberculous mycobacteria (NTM), rare immune disorders (e.g., RAG1 deficiency), and Cri du Chat syndrome (chr 5pminus;deletion) complicated by concomitant PCD, caused by mutations in DNAH5 (chr5p). Over the past 5 years of this Consortium's work, we have made remarkable progress that is already impacting on clinical practice, particularly in PCD and associated disorders. One major advance was the development of a non-invasive test for PCD (measurement of nasal nitric oxide, NO). This test is now validated as a useful clinical test for PCD, and we are participating in the European BESTCILIA grant to help them implement our methodology for nNO testing in Europe. Our Consortium played a critical role in identifying PCD-causing mutations in 28 genes, which we think will be responsible for the genetic cause of PCD in >70%) of PCD patients. We have developed a genetic test panel containing those 28 genes (Ampliseq), which is being technically validated. On the clinical side, we discovered that PCD-causing mutations are associated with heterotaxy and congenital heart disease (CHD). This discovery resulted in follow-up studies, which showed worse post-operative clinical outcomes for CHD-heterotaxy patients, and has led to a call for genetic studies of patients with CHD. Along different lines, we developed a rigorous quality-of-life (QOL) instrument for PCD, which will be a key outcome measure for therapeutic clinical trials in PCD. Finally, we have developed novel preliminary data that patients with idiopathic bronchiectasis share phenotypic features with heritable connective tissue disorders, including dural ectasia, which may reflect underlying genetic variants. Taken together, the proposed work will lead to earlier diagnoses, improved care, and more effective therapeutic interventions for rare airway diseases.

Public Health Relevance

This RDCRN Consortium research has high public health relevance to our understanding of genetic diseases of the lung. This proposal will define the clinical course and develop new genetic test panels for PCD, and define subgroups of patients with idiopathic bronchiectasis that may have underlying genetic variants that cause heritable disorders of connective tissue. The proposed work will lead to earlier diagnoses and more effective therapy for airways disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
2U54HL096458-11
Application #
8764245
Study Section
Special Emphasis Panel (ZTR1-CI-8 (01))
Program Officer
Smith, Robert A
Project Start
2004-08-06
Project End
2019-07-31
Budget Start
2014-09-19
Budget End
2015-07-31
Support Year
11
Fiscal Year
2014
Total Cost
$1,249,998
Indirect Cost
$358,505
Name
University of North Carolina Chapel Hill
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Horani, Amjad; Ferkol, Thomas W (2018) Advances in the Genetics of Primary Ciliary Dyskinesia: Clinical Implications. Chest 154:645-652
Metersky, Mark L; Aksamit, Timothy R; Barker, Alan et al. (2018) The Prevalence and Significance of Staphylococcus aureus in Patients with Non-Cystic Fibrosis Bronchiectasis. Ann Am Thorac Soc 15:365-370
Rosenfeld, Margaret; Ostrowski, Lawrence E; Zariwala, Maimoona A (2018) Primary ciliary dyskinesia: keep it on your radar. Thorax 73:101-102
Goutaki, Myrofora; Halbeisen, Florian S; Spycher, Ben D et al. (2017) Growth and nutritional status, and their association with lung function: a study from the international Primary Ciliary Dyskinesia Cohort. Eur Respir J 50:
Bustamante-Marin, Ximena M; Ostrowski, Lawrence E (2017) Cilia and Mucociliary Clearance. Cold Spring Harb Perspect Biol 9:
Lucas, Jane S; Barbato, Angelo; Collins, Samuel A et al. (2017) European Respiratory Society guidelines for the diagnosis of primary ciliary dyskinesia. Eur Respir J 49:
Behan, Laura; Leigh, Margaret W; Dell, Sharon D et al. (2017) Validation of a health-related quality of life instrument for primary ciliary dyskinesia (QOL-PCD). Thorax 72:832-839
Kristof, Arnold S; Petrof, Basil J; Hamid, Qutayba et al. (2017) An Official American Thoracic Society Workshop Report: Translational Research in Rare Respiratory Diseases. Ann Am Thorac Soc 14:1239-1247
Shapiro, Adam J; Leigh, Margaret W (2017) Value of transmission electron microscopy for primary ciliary dyskinesia diagnosis in the era of molecular medicine: Genetic defects with normal and non-diagnostic ciliary ultrastructure. Ultrastruct Pathol 41:373-385
Blackburn, Kevin; Bustamante-Marin, Ximena; Yin, Weining et al. (2017) Quantitative Proteomic Analysis of Human Airway Cilia Identifies Previously Uncharacterized Proteins of High Abundance. J Proteome Res 16:1579-1592

Showing the most recent 10 out of 64 publications